Published in J Infect Dis on January 01, 1975
Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J Clin Invest (1980) 6.61
Microbial surfaces in relation to pathogenicity. Bacteriol Rev (1977) 5.79
Colonization of porcine small intestine by Escherichia coli: ileal colonization and adhesion by pig enteropathogens that lack K88 antigen and by some acapsular mutants. Infect Immun (1976) 3.23
Escherichia coli in extra-intestinal infections. J Hyg (Lond) (1985) 2.51
Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis. Infect Immun (1979) 2.08
Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization. Infect Immun (1979) 1.68
Virulence of Escherichia coli in experimental hematogenous pyelonephritis in mice. Infect Immun (1979) 1.35
Quantitative relationship between capsular content and killing of K1-encapsulated Escherichia coli. Infect Immun (1988) 1.32
Phagocytic resistance of Escherichia coli K-1 isolates and relationship to virulence. J Clin Microbiol (1978) 1.27
Characteristics of Haemophilus pleuropneumoniae Isolates and Some Epidemiological Findings on Porcine Haemophilus Pleuropneumonia in Saskatchewan. Can Vet J (1982) 1.13
Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface. Antimicrob Agents Chemother (1990) 1.05
Physicochemical surface properties of Escherichia coli strains isolated from different types of urinary tract infections. Infect Immun (1981) 0.95
Screening for cross-reacting capsular polysaccharide K antigens of Escherichia coli using antiserum agar. J Clin Microbiol (1977) 0.87
Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med (1980) 4.45
Comparison of the antibacterial activity of rifampicin and other antibiotics. Am J Med Sci (1968) 3.03
Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med (1980) 3.03
Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli. J Immunol (1972) 2.89
Limitations of the usefulness of the Limulus assay for endotoxin. N Engl J Med (1973) 2.84
Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis (1978) 2.72
Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med (1987) 2.64
Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. N Engl J Med (1975) 2.63
Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N Engl J Med (1981) 2.56
Type-specific and cross-reactive antibodies in gram-negative bacteremia. N Engl J Med (1972) 2.42
Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals. Medicine (Baltimore) (1984) 2.28
Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med (1987) 2.04
Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis (1986) 2.04
Serum complement levels in bacteremia due to gram-negative organisms. N Engl J Med (1973) 1.70
Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med (1988) 1.58
Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants. Infect Immun (1977) 1.56
Nephrotoxicity associated with cephalothin administration. Arch Intern Med (1975) 1.40
Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant. Infect Immun (1977) 1.39
An outbreak of type 1 pneumococcal pneumonia in a men's shelter. JAMA (1980) 1.38
Bacteremia due to Fusobacterium species. Am J Med (1983) 1.35
Pseudobacteremia traced to cross-contamination by an automated blood culture analyzer. Infect Control (1984) 1.33
Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age. JAMA (1984) 1.31
Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin. J Infect Dis (1983) 1.29
Common enterobacterial antigen. I. Isolation and purification from Salmonella typhose 0:901. J Immunol (1973) 1.28
A large outbreak of infections caused by a strain of Staphylococcus aureus resistant of oxacillin and aminoglycosides. Am J Med (1981) 1.28
"Abacterial" and bacterial pyelonephritis. Immunofluorescent localization of bacterial antigen. N Engl J Med (1969) 1.28
Meningitis caused by gram-negative bacilli. Ann Intern Med (1980) 1.27
Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus. J Infect Dis (1983) 1.24
Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli. J Infect Dis (1976) 1.24
M proteins of group G streptococci isolated from bacteremic human infections. Infect Immun (1987) 1.24
Selective pressures and lipopolysaccharide subunits as determinants of resistance of clinical isolates of gram-negative bacilli to human serum. Infect Immun (1987) 1.20
Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols. Am J Med (1984) 1.14
Immunofluorescent demonstration of the common enterobacterial antigen. Proc Soc Exp Biol Med (1966) 1.12
Meningitis caused by Acinetobacter calcoaceticus var anitratus. A specific hazard in neurosurgical patients. Arch Neurol (1981) 1.11
Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria. J Infect Dis (1977) 1.07
Bacteremia due to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. A report of 9 cases and a review of the literature. Medicine (Baltimore) (1990) 1.05
Immunization with rough mutants of Salmonella minnesota: initial studies in human subjects. J Infect Dis (1988) 1.04
Gram-negative bacteremia. Adv Intern Med (1974) 1.00
The need for clinically relevant studies of non-touch disinfecting systems. J Hosp Infect (2013) 0.99
Common enterobacterial antigen. 3. Initial titers and antibody response in bacteremia caused by gram-negative bacilli. Infect Immun (1973) 0.93
Immunofluorescent localization of bacterial antigen in pyelonephritis. I. The use of antisera against the common enterobacterial antigen in experimental renal lesions. J Lab Clin Med (1967) 0.93
Endotoxin and bacteremia due to gram-negative organisms. N Engl J Med (1970) 0.91
Bacteremia caused by group G streptococci in parenteral drug abusers: epidemiological and clinical aspects. J Infect Dis (1986) 0.90
Contamination of mechanical ventilators with tubing changes every 24 or 48 hours. N Engl J Med (1982) 0.89
Bacterial interference induced in embryonated eggs by staphylococci. J Clin Invest (1967) 0.88
Common enterobacterial antigen. II. Effect of immunization on challenge with heterologous bacilli. Infect Immun (1973) 0.87
Antibiotics and endotoxic shock. Bull N Y Acad Med (1975) 0.84
Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping. Arch Dermatol (1996) 0.83
Naloxone versus placebo in treatment of septic shock. Lancet (1985) 0.83
A randomized study comparing a transparent polyurethane dressing to a dry gauze dressing for peripheral intravenous catheter sites. Infect Control (1985) 0.83
Methicillin-resistant Staphylococcus aureus bacteremia linked to intravenous drug abusers using a "shooting gallery". Am J Med (1986) 0.83
Clinical use of combinations of antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1967) 0.82
Interactions of rifampin and trimethoprim in vitro. Rev Infect Dis (1982) 0.81
Evaluating the thoroughness of environmental cleaning in hospitals. J Hosp Infect (2008) 0.81
Endotoxin-associated protein: a potent stimulus for human granulocytopoietic activity which may be accessory cell independent. Infect Immun (1988) 0.81
Endotoxin-associated protein: interleukin-1-like activity on serum amyloid A synthesis and T-lymphocyte activation. Infect Immun (1988) 0.80
The role of lipopolysaccharide of gram-negative bacilli in sensitivity and resistance to serum. Prog Clin Biol Res (1988) 0.80
Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli. Antimicrob Agents Chemother (1989) 0.80
Xanthogranulomatous pyelonephritis caused by methicillin-resistant Staphylococcus aureus. Am J Med (1984) 0.79
Gram-negative bacteremia. Dis Mon (1973) 0.79
Pathophysiology of bacteremia. Am J Med (1983) 0.79
Potential use of shared antigens for immunization against gram-negative bacillary infections. Prog Clin Biol Res (1980) 0.78
Studies of staphylococcal infections. II. The role of bacteriophage type, antibiotic resistance, coagulase, and other exotoxins in infections in embryonated eggs. Yale J Biol Med (1966) 0.78
Ototoxicity of erythromycin. Lancet (1978) 0.77
Empiric therapy for bacterial meningitis. Rev Infect Dis (1983) 0.77
Antibody to endotoxin in the treatment of gram-negative sepsis. JAMA (1992) 0.77
Humoral immunity to gram-negative bacillary infections in experimental animals and man. Infection (1975) 0.76
All that glistens may be neither gold nor clean. J Hosp Infect (2010) 0.75
Sir Thomas Sydenham revisited. Clin Infect Dis (2001) 0.75
Gram-negative rod bacteremia in cancer patients. A review with emphasis on the antibody response. Eur J Cancer (1975) 0.75
In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria. Infection (1980) 0.75
A model for bacterial clearance in the lung. Surgery (1972) 0.75
Naloxone in septic shock. Lancet (1985) 0.75
A clinical study of moxalactam in the treatment of infections due to gram-negative bacilli. Scand J Infect Dis (1984) 0.75
Detection of bacterial antigen in bacterial and "abacterial" pyelonephritis. Trans Assoc Am Physicians (1969) 0.75
The correlation of in vitro tests with the outcome of antimicrobial therapy for otitis media. Pediatr Ann (1984) 0.75
Trichinosis. Report of a small outbreak with observations of thiabendazole therapy. Arch Intern Med (1967) 0.75
Letter: Incidence of gram-negative bacteremia. N Engl J Med (1975) 0.75
University of California/Davis Interdepartmental Conference on gram-negative septicemia. Rev Infect Dis (1991) 0.75
Intracerebral hemorrhage caused by cerebral amyloid angiopathy in a 53-year-old man. J Neurol (2008) 0.75
Adult bacteremia caused by gram-negative bacilli. Clin Obstet Gynecol (1979) 0.75
Lister's granuligera. J Hosp Infect (2009) 0.75
Immunoprophylaxis of gram-negative bacillary infections. Annu Rev Med (1976) 0.75
Role of the reticuloendothelial system in bacterial interference in embryonated eggs. J Lab Clin Med (1968) 0.75
Fournier's gangrene: an approach to its management. J Urol (1983) 0.75